Total planned funding: $162,751,136
Allocations
Countries/Regions
India | $162,751,136 |
Organizational Types
Unknown | $105,415,899 |
NGO | $21,695,145 |
Own Agency | $21,673,284 |
University | $4,100,000 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,656,808 |
Private Contractor | $2,409,000 |
FBO | $1,100,000 |
Host Country Government Agency | $601,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $66,016,184 |
Prevention | $40,021,167 |
Care | $18,054,307 |
Management and Operations | $17,290,869 |
Testing | $8,938,357 |
Treatment | $8,002,460 |
Budget Codes
OHSS: Health Systems Strengthening | $37,563,928 |
HVSI: Strategic Information | $23,462,132 |
HVOP: Sexual Prevention: Other Sexual Prevention | $18,262,434 |
HVMS: Management and Operations | $17,290,869 |
HBHC: Care: Adult Care and Support | $12,601,162 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,239,957 |
HVCT: Testing: HIV Testing and Counseling | $8,938,357 |
HTXS: Treatment: Adult Treatment | $7,644,189 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,621,130 |
HLAB: Laboratory Infrastructure | $4,990,124 |
HKID: Care: Orphans and Vulnerable Children | $3,465,560 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,383,379 |
HMBL: Biomedical Prevention: Blood Safety | $2,514,267 |
HVTB: Care: TB/HIV | $1,917,585 |
PDTX: Treatment: Pediatric Treatment | $334,794 |
PDCS: Care: Pediatric Care and Support | $70,000 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$105,415,899
Countries/Regions
FHI 360:
$14,887,057
Countries/Regions
USG Aggregated Agencies:
$13,982,832
Countries/Regions
University of Washington:
$4,100,000
Countries/Regions